Novel sources for potent and selective GPCR modulators
Markus Muttenthaler(The University of Queensland), P.F. Alewood, Åsa Andersson, Philip E. Dawson(Scripps Research Institute), Richard J. Lewis(AstraZeneca (Netherlands)), Irina Vetter(Centre National de la Recherche Scientifique), Michael Freissmuth(Pharmacology Research Institute), C. W. Gruber, Sébastien Dutertre(École Nationale Supérieure de Chimie de Montpellier), Christian Bergmayr(Medical University of Vienna)
Queensland's institutional digital repository (The University of Queensland)
January 1, 2012
Cited by 0
Related Papers
Natural products in drug discovery: advances and opportunities
|Nature Reviews Drug Discovery|2021|5.2k
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654